BIOMAT Database Logo BIOMAT Database Logo

Acute non-lymphocytic leukemia. 1979

C D Bloomfield

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

C D Bloomfield
Cytogenetics and acute non lymphocytic leukemia.
January 1987, Annales de genetique,
C D Bloomfield
Treatment of adult acute non-lymphocytic leukemia.
January 1975, Rocky Mountain medical journal,
C D Bloomfield
Granulocytic sarcoma in acute non-lymphocytic leukemia.
May 1996, Indian pediatrics,
C D Bloomfield
The treatment of acute non-lymphocytic leukemia.
June 1987, Blood reviews,
C D Bloomfield
Acute non-lymphocytic leukemia in elderly patients.
July 1979, Minnesota medicine,
C D Bloomfield
Klinefelter's syndrome and acute non-lymphocytic leukemia.
January 1982, Blut,
C D Bloomfield
Acute non-lymphocytic leukemia with t(16;21).
October 1993, Cancer genetics and cytogenetics,
C D Bloomfield
Cytogenetics of secondary acute non-lymphocytic leukemia.
January 1987, Haematologica,
C D Bloomfield
[Hepatosplenic candidiasis in acute non-lymphocytic leukemia].
July 1991, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
C D Bloomfield
HLA-Dr negative acute non-lymphocytic leukemia.
January 1998, Annals of clinical and laboratory science,
Copied contents to your clipboard!